2024年4月16日 · Published monthly, in print and online, Nature Reviews Cancer offers a mix of research news, reviews and opinion.

2025年1月14日 · In this Review, Fu, Mo and Ivanov summarize the mechanisms by which oncogenic mutations impact PPIs, technologies for monitoring this, the categories and features of PPIs in cancer, and finally...

2025年1月14日 · In this Review, Erez and colleagues examine the complex interactions among tumours, their microenvironment and the host, shaping a metabolic macroenvironment that drives cancer progression.

2019年8月27日 · This Analysis article reviews these findings and the indications that G proteins, GPCRs and their signalling pathways represent novel therapeutic targets for cancer prevention and treatment.

2025年1月20日 · In this Review, Erez and colleagues examine the complex interactions among tumours, their microenvironment and the host, shaping a metabolic macroenvironment that drives cancer progression. They ...

2023年7月24日 · In this Review, Jassim et al. outline the various theories that have currently been proposed for cancer origins, and the determinants of cancer risk upon which they are based.

2022年12月5日 · In this Review, Cybulla and Vindigni discuss the many connections between DDT, replication stress and cancer, detail opportunities for clinical biomarker development, and outline therapeutic ...

Nature Reviews Cancer is a monthly review journal covering the field of oncology. It was established in 2001. [1] The editor-in-chief is Anna Dart. [2]

2025年1月21日 · In summary, the addition of pembrolizumab to neoadjuvant chemotherapy significantly improved the pathological complete response rate in patients with high-risk, early-stage ER+/HER2− breast cancer.

2025年1月21日 · In the CheckMate 7FL trial, neoadjuvant nivolumab and chemotherapy in patients with newly diagnosed, high-risk estrogen receptor-positive breast cancer led to an increased pathological complete ...